FDA Colloquia: In Silico Modeling and Methods for Food Ingredient, Dietary Supplement, and Cosmetic
Drivers for the Application and Acceptance of In Silico Safety Assessment Based on Chemical Exposure Mark Cronin, Liverpool John Moores University, Liverpool, UK Current Issues of Uncertainty in In Silico Methods James F. Rathman, The Ohio State University, Columbus, OH A Case Study on PBPK and Biologically Based Dose-Response Modeling for Safety Assessment Considerations: Utility and Challenges Annie Lumen, NCTR, Jefferson, AR Transformation of Threshold of Toxicological Concerns (TTC) to Internal TTC: Why Internal Exposure Matters and How We Will Get There Corie Ellison, Procter and Gamble, West Chester, OH
Chair: Kirk Arvidson, US FDA, College Park, MD Co-chair: Chihae Yang, MN AM, Nurnberg, Germany Overview This colloquium will feature the science behind new international trends in the in silico safety assessment of chemical exposure. Two common themes shared by international regulatory bodies are the critical issues involved in alternative methods to animal testing and the rigorous treatment of uncertainties to obtain reproducible and transparent weight-of-evidence approaches to decision making. For alternative methods to repeated-dose toxicity, toxicokinetics and metabolism are emphasized to understand chemical exposure and bioavailability. Biokinetics is further being applied to data-waiving methods such as the Threshold of Toxicological Concerns (TTC). Internal TTC is a TTC concept for situations of low internal exposure, where this value is more relevant than the external exposure. Development of internal TTCs requires a significant amount of data and computational tools (e.g., PBPK modeling) to convert the chemical specific external doses (i.e., NOAELs) in the TTC databases into an estimate of the internal exposure. The common concerns related to the relevance of in silico chemical safety assessment that may hinder its adoption if not properly addressed will be discussed.